Categories Earnings, Retail

Kirkland’s (NASDAQ: KIRK): Q3 2019 Earnings Snapshot

— Kirkland’s Inc. (NASDAQ: KIRK) reported a third-quarter 2019 adjusted loss of $0.58 per share versus a loss of $0.50 per share expected.

— Net sales fell by 6.2% to $144.9 million versus $137.17 million expected. Kirkland’s opened one store and closed no store during the third quarter, bringing the total number of stores to 432 at quarter-end.

Earnings Update by AlphaStreet

— Comparable store sales, including e-commerce sales, decreased 6.4% compared to an increase of 1.4% in the prior-year quarter. Store sales were impacted by negative store traffic, which was partially offset by an improvement in conversion.

— The company recorded growth in e-commerce sales, which were driven by gains in traffic and conversion, partially offset by a decline in average ticket.

— Looking ahead into fiscal 2019, adjusted loss guidance is widened to the range of $2.00-1.75 per share from the previous range of $1.50-1.25 per share. The consensus estimates loss of $1.39 per share.

— The forecast reflected continued pressure on revenue and gross margin as the company moves forward on its various business improvement initiatives.

Get access to timely and accurate verbatim transcripts that are published within hours of the event.

Most Popular

PM Earnings: Key quarterly highlights from Philip Morris Q3 financial results

Philip Morris International Inc. (NYSE: PM) reported Third-quarter 2021 earnings results today. Net revenues increased 9% year-over-year to $8.1 billion. The reported net income amounted to $2.42 billion compared to

Halliburton stock slips on weaker-than-expected Q3 results

Halliburton (NYSE: HAL) reported third-quarter 2021 financial results before the regular market hours on Tuesday. The company reported Q3 revenue of $3.9 billion, up 30% year-over-year and lower than the

Johnson & Johnson (JNJ) reports Q3 2021 earnings

Johnson & Johnson (NYSE: JNJ) reported third-quarter 2021 financial results before the regular market hours on Tuesday. The pharmaceutical giant reported revenue of $23.3 billion, up 10.7% year-over-year, with operational

Add Comment
Loading...
Cancel
Viewing Highlight
Loading...
Highlight
Close
Top